Work

Predicting overall survival (OS) and overall response (OR) following durvalumab treatment in patients with multiple cancer types using a hybrid modeling strategy.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.e15161

Authors: Ting Chen, Yanan Zheng, Lorin Roskos, Donald E Mager

Institutions: University at Buffalo, State University of New York, AstraZeneca (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3032300842

Cites:

Cited by: 1

Related to: 10